Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Changes in serum adiponectin concentrations and endothelial function after intensive insulin treatment in people with newly diagnosed type 2 diabetes: a pilot study.

Li F, Zhao T, Wen X.

Diabetes Res Clin Pract. 2011 Nov;94(2):186-92. doi: 10.1016/j.diabres.2011.07.036. Epub 2011 Aug 25.

PMID:
21871685
2.

Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes.

Martens FM, Visseren FL, de Koning EJ, Rabelink TJ.

J Cardiovasc Pharmacol. 2005 Dec;46(6):773-8.

PMID:
16306801
3.

The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.

Caballero AE, Saouaf R, Lim SC, Hamdy O, Abou-Elenin K, O'Connor C, Logerfo FW, Horton ES, Veves A.

Metabolism. 2003 Feb;52(2):173-80.

PMID:
12601628
4.

Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms.

Fernandez M, Triplitt C, Wajcberg E, Sriwijilkamol AA, Musi N, Cusi K, DeFronzo R, Cersosimo E.

Diabetes Care. 2008 Jan;31(1):121-7. Epub 2007 Oct 1.

PMID:
17909084
5.

Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis.

Antoniades C, Tousoulis D, Marinou K, Papageorgiou N, Bosinakou E, Tsioufis C, Stefanadi E, Latsios G, Tentolouris C, Siasos G, Stefanadis C.

Clin Cardiol. 2007 Jun;30(6):295-300.

6.

Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.

Sharma PK, Bhansali A, Sialy R, Malhotra S, Pandhi P.

Clin Endocrinol (Oxf). 2006 Dec;65(6):722-8.

PMID:
17121522
8.

Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.

Erdem G, Dogru T, Tasci I, Sonmez A, Tapan S.

Exp Clin Endocrinol Diabetes. 2008 May;116(5):289-92. doi: 10.1055/s-2007-1004564.

PMID:
18484561
9.
10.

Improved endothelial function with metformin in type 2 diabetes mellitus.

Mather KJ, Verma S, Anderson TJ.

J Am Coll Cardiol. 2001 Apr;37(5):1344-50.

11.

Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.

De Jager J, Kooy A, Lehert P, Bets D, Wulffelé MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJ, Stehouwer CD.

J Intern Med. 2005 Jan;257(1):100-9.

12.
13.

Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.

Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS.

Diabetes Care. 1995 Aug;18(8):1113-23.

PMID:
7587846
14.

Hypoadiponectinemia predicts impaired endothelium-independent vasodilation in newly diagnosed type 2 diabetic patients: an 8-year prospective study.

Li H, Xiao Y, Liu H, Chen XY, Li XY, Tang WL, Liu SP, Xu AM, Zhou ZG.

Chin Med J (Engl). 2011 Nov;124(22):3607-12.

PMID:
22340211
15.

Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.

Kadoglou NP, Kapelouzou A, Tsanikidis H, Vitta I, Liapis CD, Sailer N.

Exp Clin Endocrinol Diabetes. 2011 Feb;119(2):63-8. doi: 10.1055/s-0030-1265174. Epub 2010 Oct 28.

PMID:
21031343
16.

Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes.

Chen LL, Yu F, Zeng TS, Liao YF, Li YM, Ding HC.

Eur J Pharmacol. 2011 Jun 1;659(2-3):296-301. doi: 10.1016/j.ejphar.2011.02.044. Epub 2011 Mar 29.

PMID:
21453695
17.

Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy.

Bellia A, Rizza S, Lombardo MF, Donadel G, Fabiano R, Andreadi K, Quon MJ, Sbraccia P, Federici M, Tesauro M, Cardillo C, Lauro D.

Atherosclerosis. 2012 Jul;223(1):197-203. doi: 10.1016/j.atherosclerosis.2012.04.015. Epub 2012 May 8.

PMID:
22658255
18.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
19.

Effect of Danzhijiangtang capsule on monocyte chemoattractant protein-1 mRNA expression in newly diagnosed diabetes subclinical vascular lesions.

Fang ZH, Liu Y, Bao TT, Ni YQ, Liu J, Shi GB, Wu JP, Yang JP, Zhang H.

World J Gastroenterol. 2013 May 21;19(19):2963-8. doi: 10.3748/wjg.v19.i19.2963.

20.

[Effects of rosiglitazone on endothelium-dependent vasodilation in patients with Type 2 diabetes].

Wu J, Lei MX, Liu L, Huang YJ.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006 Aug;31(4):570-4. Chinese.

Supplemental Content

Support Center